The immunoreactivity for LAT1 was previously identified in biopsy samples from a glioma (Haining et al. 2012), indicating that LAT1 might be a molecular target for diagnostic imaging (Nawashiro et al. 2006). The gene discussed is SLC7A5; the disease is central nervous system cancer.